Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Jmd Properties Inc (JMDP)

Jmd Properties Inc (JMDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stella Diagnostics Announces Completion of Corporate Name and Ticker Symbol Changes (SLDX)

SALT LAKE CITY, UT / ACCESSWIRE / April 16, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP) ("Stella" or "The Company") announced today that its corporate name change from "JMP Properties, Inc." to "Stella......

JMDP : 0.5505 (+10.10%)
Stella Diagnostics to Present at the Benzinga Biotech Small Cap Conference

SALT LAKE CITY, UT / ACCESSWIRE / March 23, 2021 / Stella Diagnostics, Inc. (OTC Markets:JMDP) ("Stella" or "The Company") announced today that the Company's Chief Executive Officer, Dr. Joe Abdo, will...

JMDP : 0.5505 (+10.10%)
Stella Diagnostics and the University of Kansas Medical Center Enter Into Collaborative Research Agreement

KANSAS CITY, KS / ACCESSWIRE / March 16, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP) ("Stella" or "The Company") has announced a Collaborative Research Agreement with the University of Kansas Medical...

JMDP : 0.5505 (+10.10%)
Stella Diagnostics Announces Key Additions to its Board of Directors

SALT LAKE CITY, UT / ACCESSWIRE / February 25, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP) ("Stella" or "The Company") today announced that it has appointed Peter A. Cohen, Seth Platt, and David Seaburg...

JMDP : 0.5505 (+10.10%)
Stella Diagnostics and Mayo Clinic Enter Into Collaborative Research Agreement

SALT LAKE CITY, UT / ACCESSWIRE / February 17, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP) ("Stella" or "The Company") announced today that they have entered into a Collaborative Research Agreement...

JMDP : 0.5505 (+10.10%)
Stella Diagnostics Announces Partnership with mProbe Laboratories

PALO ALTO, CA / ACCESSWIRE / February 4, 2021 /Stella Diagnostics, Inc. (OTC PINK:JMDP) ("Stella" or "The Company") announced today that they have entered into a partnership with mProbe, Inc., a leading...

JMDP : 0.5505 (+10.10%)
Stella Diagnostics to Present at 23rd Annual ICR Conference

SALT LAKE CITY, UT / ACCESSWIRE / January 7, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP), a molecular diagnostics-based organization focused on improving patient management strategies for people living...

JMDP : 0.5505 (+10.10%)
Stella Diagnostics CEO Joe Abdo featured on Global Cancer Advocacy Podcast 'Out of Patients with Matthew Zachary'

NEW YORK, NY / ACCESSWIRE / November 5, 2020 / Stella Diagnostics, Inc. (OTC PINK:JMDP), a molecular diagnostics-based organization focused on improving patient management strategies for people living...

JMDP : 0.5505 (+10.10%)
Stella Diagnostics to Present Data on Discovery of Proteomic Chemoresistance Network in Esophageal Cancer Tissue

NEW YORK, NY / ACCESSWIRE / October 22, 2020 / Stella Diagnostics, Inc. (OTC PINK:JMDP), a molecular diagnostics-based organization focused on improving patient management strategies for over 67 million...

JMDP : 0.5505 (+10.10%)
Stella Diagnostics Selected as Buzz of BIO Winner for the 2020 BIO Investor Forum Digital

Stella Diagnostics, Inc . (OTC Markets: JMDP), a molecular diagnostics-based organization focused on improving patient management strategies for over 67 million people living with severe esophageal disease,...

JMDP : 0.5505 (+10.10%)

Barchart Exclusives

Is This Pullback Your Best Chance to Buy Nvidia Stock?
As Nvidia experiences a pullback of approximately 18% from its recent highs, investors might be contemplating whether this presents an opportune moment to scoop up the stock. With concerns about valuation easing and analysts growing more bullish, this analysis explores whether now is the optimal time to consider investing in Nvidia. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar